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Abstract: Obesity is a major risk factor for a plethora of metabolic disturbances including diabetes
and cardiovascular disease. Accumulating evidence is showing that there is an adipose tissue
depot-dependent relationship with obesity-induced metabolic dysfunction. While some adipose
depots, such as subcutaneous fat, are generally metabolically innocuous, others such as visceral fat,
are directly deleterious. A lesser known visceral adipose depot is the pericardial adipose tissue depot.
We therefore set out to examine its transcriptional and morphological signature under chow and
high-fat fed conditions, in comparison with other adipose depots, using a mouse model. Our results
revealed that under chow conditions pericardial adipose tissue has uncoupling-protein 1 gene
expression levels which are significantly higher than classical subcutaneous and visceral adipose
depots. We also observed that under high-fat diet conditions, the pericardial adipose depot exhibits
greatly upregulated transcript levels of inflammatory cytokines. Our results collectively indicate,
for the first time, that the pericardial adipose tissue possesses a unique transcriptional and histological
signature which has features of both a beige (brown fat-like) but also pro-inflammatory depot, such as
visceral fat. This unique profile may be involved in metabolic dysfunction associated with obesity.
Keywords: adipose tissue; obesity; metabolism
1. Introduction
Obesity is a major risk factor for a plethora of metabolic disturbances and diseases, including
heart disease, which is a leading cause of death in most industrialised countries [1]. Ectopic fat
deposition, which may refer to accumulation of triglycerides beyond the adipose tissue or the presence
of non-classical adipose tissue depots is commonly associated with increased cardiovascular risk
and poorer clinical outcomes [2,3], with a number of genetic determinants of ectopic fat having been
identified [4].
The classical adipose tissue depots can be classified into two major types: white adipose tissue
(WAT) and brown adipose tissue (BAT), the latter of which is concerned with thermogenesis and
lipolysis, while the former is associated with lipid storage [5,6]. WAT is comprised of a range of
depots, which are anatomically, genetically and functionally distinct [7,8]. In humans and animals,
visceral WAT depots include intra-abdominal fat and gonadal fat, respectively. These depots are
associated with metabolically deleterious hypertrophic adipose tissue growth and inflammation,
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whereas, subcutaneous WAT depots are associated with lower inflammatory profiles and reduced
cardiometabolic risk [9,10].
The human heart is in proximity to numerous adipose tissue depots, the nomenclature and
classification of which has in the past been the subject of confusion [11,12]. These include epicardial
adipose tissue (EAT), pericardial adipose tissue (PAT) and perivascular adipose tissue (PVAT) [11,13],
as indicated in Figure 1. It is now established that while there may be an overlap in their embryonic
origins, the ectopic fat depots within the vicinity of the heart are anatomically distinct and may
have specific physiological relevance regarding the pathogenesis of obesity-associated cardiovascular
disease [11–13]. While EAT is located between the myocardium and the inner layer of the pericardium,
PAT is not in contact with the myocardium and is located anterior to the pericardial sac. (Figure 1B).
The distinction between the epicardial and pericardial adipose depots was defined clearly in a recent
review [14].
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Figure 1. The location of epicardial adipose tissue (EAT), pericardial adipose tissue (PAT) and
perivascular adipose tissue (PVAT) associated with the heart in rodents (A) and diagrammatically in
humans (B). EAT is absent in the heart of rodents but present in the heart of human.
Human EAT, which can be observed through various imaging modalities, shares a vascular
network with the myocardium and is thus uniquely positioned to impact cardiovascular risk [15,16].
As with classical visceral adipose tissue, both pericardial and epicardial depots in humans have
been linked with increased inflammatory profiles and various measures of cardiometabolic risk,
including vascular calcification and their expansion in obesity potentially play important roles in
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the pathophysiology of cardiovascular disease and clinical outcomes [17–20]. Interestingly, human
EAT has been shown to have genetic and histological signatures that resemble a thermogenic or
‘beige’ adipose tissue depot [21]. Recent studies in mice have suggested that PAT has unique genetic
signatures compared to other classical adipose depots, though such studies have not included detailed
transcriptional and histological analyses under di↵erent dietary paradigms [22,23].
EAT is the most extensively studied cardiovascular adipose depot in humans but appears to
be absent in rodents [23]. PAT is present in both rodents and humans, and its volume is positively
correlated with obesity-related metabolic syndrome and cardiac abnormalities [17,23,24]. Given the
importance of the mouse in modelling metabolic disease processes associated with obesity, surprisingly
little is known about how mouse PAT compares to that of classical adipose tissues, transcriptionally
and histologically. We therefore explored the transcriptional signatures of PAT, with a specific focus
of inflammatory, thermogenic and adipogenic genes, to determine whether distinctive expression
profiles in this adipose tissue underlie distinctive function and potential relationship to cardiovascular
dysfunction. We also assessed the morphological characteristics of PAT through histological analysis.
Our results demonstrate that PAT depot has unique genetic and histological signatures,
with thermogenic gene profiles that are intermediate between subcutaneous and brown fat depots,
but also having an inflammatory transcriptional profile comparable to that of visceral adipose tissue.
This study may have important experimental and clinically relevant implications that further our
understanding of the role of pericardial adipose tissue in metabolic disease.
2. Methods
2.1. Animal and Experimental Design
All animal studies were approved by the Medical Research Council Harwell Institute Animal
Welfare and Ethical Review Board, and all procedures were carried out within project license restrictions
(PPL 30/3146) under the UK Animals (Scientific Procedures) Act 1986, issued by the UK Government
Home O ce. All mice were maintained on 12 hr light:dark cycle with ad libitum access to food.
Four-week old male C57BL6/N mice were randomly assigned to either a chow (C, 10% kCal fat) or
high fat (HF, 60% kCal fat) for 26 weeks. Throughout the dietary intervention, mice were weighed
weekly, metabolic cage analysis performed at 22 weeks using TSE PhenoMaster in vivo calorimetry
system, whilst body composition and intraperitoneal glucose tolerance test (ipGTT) were measured
at 26 weeks of age. At 30 weeks of age, blood was collected by cardiac puncture under terminal
anaesthetic. For serological analysis, blood was allowed to clot, then centrifuged at 3000 ⇥ g for 3 min
and sera frozen at  80  C until analysis. All samples for serum biochemistry analyses including
cholesterol, fatty acids and triglycerides analysis were conducted using an AU680 Clinical Chemistry
Analyser (Beckman Coulter, HighWycombe, UK), by the Clinical Chemistry core facility, MRCHarwell
Institute (Oxfordshire, UK) using commercially-available kits and performed according tomanufacturer
instructions. Body composition was measured at 26 weeks of age by nuclear magnetic resonance
(EchoMRI™, Zinsser Analytic GmbH, Eschborn, Germany) which determined total body fat, lean mass
and free fluid in grams. The percentage of each component was then calculated based on the total body
weight of the animal. Intraperitoneal glucose tolerance tests were performed at 26 weeks following an
8-h fast. Specifically, fasted mice received an i.p. administration of 2 g/kg glucose and blood sampled
from the tail vein under a local anaesthetic (EMLA cream, AstraZeneca, Cambridge, UK) at 0 min
(baseline), 15, 30, 60 and 120 min post glucose injection. Whole blood glucose was measured using an
AlphaTRAK meter and test strips (Abbott Animal Health, Kent, UK).
2.2. RNA Isolation
One millilitre (1 mL) of Invitrogen™ TRI Reagent™ Solution per 50 mg to 100 mg of gonadal
white adipose tissue (gWAT), inguinal white adipose tissue (iWAT), intercapsular brown adipose tissue
(iBAT) and pericardial adipose tissue (PAT) was transferred to a MP BiomedicalsTM Lysing Matrix
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D tube. Lysing tubes were placed in the MP Biomedicals™ FastPrep-24™ 5G Instrument, with the
QuickPrep Adaptor (Fisher Scientific) and homogenised at a speed of 6.0 m/s, for 40 s. Isolation of
RNA was performed as recommended by the manufactures of Invitrogen™ TRI Reagent™ Solution
(Fisher Scientific).
2.3. cDNA Synthesis and qRT-PCR
Total RNAwas reverse transcribed using the Applied Biosystems™High-Capacity cDNA Reverse
Transcription Kit (Fisher Scientific) and Invitrogen™RNaseOUT™Recombinant Ribonuclease Inhibitor
(Fisher Scientific) following the instructions as recommended by the manufacturer to synthesise
cDNA, performed using the T100™ Thermal cycler (Bio-Rad). The gene expression of 30 ng cDNA
was determined using qPCRBIO Probe Mix No-ROX (PCR Biosystems), performed on the MyiQ™
Single-Colour Real-Time PCR Detection System (Bio-Rad). Samples were measured in duplicates and
the fold change in gene expression levels were determined using the comparative threshold cycle (CT)
method, also referred to as the 2 DDCt method. The target genes listed below were normalized to the
housekeeping gene, peptidylprolyl isomerase A (PPIA). All Applied Biosystems™ TaqMan™ Gene
Expression Assay (FAM-MGB) (Table 1) were purchased from Fisher Scientific.
Table 1. List of TaqMan™ Gene Expression Assays
Gene Assay ID
AdipoQ Mm00456425_m1
ADR 3 Mm02601819_g1
C/EBP↵ Mm00514283_s1
COX7A1 Mm00438297_g1
COX8B Mm00432648_m1
DIO2 Mm00515664_m1
FABP4 Mm00445878_m1
IL6 Mm00446190_m1
Leptin Mm00434759_m1
PGC1↵ Mm01208835_m1
PPAR  Mm00440940_m1
PPIA Mm02342430_g1
TNF↵ Mm00443258_m1
UCP1 Mm01244861_m1
2.4. Histology
Formalin fixed gWAT, iWAT and PAT embedded in Optimal Cutting Temperature (OCT)
compound were sectioned between 10 µm and 15 µm using a Bright 5040 Cryostat (Bright Instruments
Limited). Sections were stained with Haematoxylin and Eosin (H&E) and imaged with a Nikon TE200
Brightfield Inverted Microscope at 40⇥ objective lens. Assuming the shape of adipocytes are spherical,
to calculate adipocyte volume, Image-J software was used to determine adipocyte area, as stated below.
The percentage change in volume was determined by normalising adipocyte volume to the chow-fed
mice, unless stated otherwise, and multiplying by 100.
To determine adipocyte volume from adipocyte area:
Radius =
p
(Area/⇡)
Radius3 = Radiusˆ3
Volume of a sphere = (4/3)⇤(⇡⇤Radius3)
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To assess the adipocyte size distribution pattern the raw values of the adipocyte, volumes derived
from image-J were used to determine the frequency distribution of cells. This was achieved by using the
frequency function as an array formula in excel and calculating the percentage of cells present within
each cell volume category (binning) across the adipocyte size spectrum (presented as arbitrary units).
2.5. Statistical Analysis
GraphPad Prism 8 was used to perform statistical analysis of one-way ANOVA (with post-hoc
Tukey’s comparison), unpaired t-test or Pearson’s correlation coe cient. All values are expressed as
mean + standard error of the mean (s.e.m). A value of p < 0.05 was deemed as statistically significant
with * p < 0.05, ** p < 0.01, *** p < 0.001 and **** p < 0.0001.
3. Results
3.1. Adipose Tissue Gene Expression Di↵erences at Baseline in Chow-Fed Mice
For comparison of the transcriptional alterations occurring at baseline, markers associated
with adipogenesis (Figure 2A–C), inflammation (Figure 2D–G), thermogenesis (Figure 2H–J) and
mitochondrial function (Figure 2K–M)were assessed in gWAT, iWAT, iBATandPAT, in 30-week-oldmale
mice fed a standard chow diet. The gene expression of fatty acid-binding protein 4 (FABP4) (Figure 2A),
an adipocyte terminal di↵erentiation marker, was significantly lower, with a ~50% decrease in PAT
compared to iWAT (p < 0.05) and gWAT (p < 0.05). In addition, the ‘master regulators of adipogenesis’,
peroxisome proliferator-activated receptor gamma (PPAR ) (Figure 2B) and CCAAT/enhancer binding
protein (C/EBP↵) (Figure 2C), exhibited a similar transcriptional profile, but only iBAT showed a
significant reduction in PPAR  gene expression compared to iWAT (p < 0.05), with no other significant
changes between the adipose tissue depots in these genes. In this case, PAT from chow-fed mice
resembles a similar gene expression level of pro-adipogenic markers as gWAT, at baseline.
The response to pro-inflammatory, depot-specific markers was assessed by observing the changes
in the transcript levels of interleukin 6 (IL6) (Figure 2D) and tumour necrosis factor alpha (TNF↵)
(Figure 2E). A significantly higher expression of the pro-inflammatory cytokine TNF↵ in PAT compared
to BAT (p < 0.01) was observed. Although there were no significant changes in IL6 expression, iBAT IL6
expression was >40% lower compared to gWAT, iWAT and PAT.
As well as IL6 and TNF↵, adipocytes also secrete pro-inflammatory adipokines, such as
leptin (Figure 2F), and anti-inflammatory adipokines, such as adiponectin (AdipoQ) (Figure 2G).
The transcription levels between the four adipose tissue depots illustrate a similar profile in both
leptin and AdipoQ, with gWAT exhibiting the highest levels of expression (1.22 and 1.07, respectively)
followed by iWAT (1.07 and 0.81, respectively), PAT (0.30 and 0.36, respectively) and iBAT (0.14 and
0.29, respectively). A significantly lower expression of leptin in iBAT compared to gWAT (p < 0.01)
and iWAT (p < 0.05) was observed. There was also a significantly lower expression of leptin in PAT
compared to gWAT (p < 0.05) and a strong trend towards a lower expression level of leptin in PAT
compared to iWAT (p = 0.0771). AdipoQ levels in iBAT and PAT displayed lower expression compared
with iWAT (p < 0.001 and p < 0.01, respectively) and gWAT (p < 0.0001 and p < 0.0001, respectively).
Brown adipose tissue specific markers such as uncoupling protein 1 (UCP1) (Figure 2H), beta-3
adrenergic receptor (ADR 3) (Figure 2I) and deiodinase 2 (DIO2) (Figure 2J), play a role in the
thermogenic and lipolytic properties of the tissue. UCP1 levels were significantly higher in iBAT than
those of gWAT (p < 0.0001) by >20,000-fold increase and iWAT with >50-fold increase (p < 0.0001) and
>2-fold higher than that of PAT (p < 0.001). In fact, PAT UCP1 levels were >9000 fold higher than gWAT
(p < 0.01) and >20-fold higher than iWAT (p < 0.01). On the contrary, ADR 3 levels were highest in
gWAT (1.32) compared to 0.59 in iWAT (p < 0.05), 0.43 in iBAT (p < 0.01) and 0.43 in PAT (p < 0.01),
with no significant di↵erences amongst other depots. Similar to UCP1, DIO2 showed a similar profile
as UCP1, in which expression was significantly higher in iBAT (19.86) and PAT (17.80) compared to a
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transcript level of 3.92 in iWAT (p < 0.01 and p < 0.01, respectively) and a transcript level of 1.10 in
gWAT (p < 0.001 and p < 0.01), respectively).
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Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC1↵) (Figure 2K) and
cytochrome c oxidase subunit 7A1 (COX7A1) (Figure 2L) and 8B (COX8B) (Figure 2M) are well known
markers to determine mitochondrial function. As with UCP1 transcript levels, PGC1↵, COX7A1 and
COX8B levels were highest in iBAT (7.93, 112.4 and 50.41, respectively), intermediate in PAT (4.17, 42.31
and 19.50, respectively) and lowest in iWAT (2.45, 3.34 and 4.39, respectively) and gWAT (1.18, 1.09 and
1.15, respectively). For PGC1↵, statistically significant di↵erences were observed in iBAT compared to
iWAT (p < 0.001), gWAT (p < 0.0001) and PAT (p < 0.05). While iBAT COX7A1 and COX8B expression
were significantly higher than those of gWAT (p <0.0001 and p < 0.0001, respectively), iWAT (p < 0.0001
and p < 0.0001, respectively) and PAT (p < 0.0001 and p < 0.0001, respectively), expression levels were
significantly higher in PAT compared to gWAT (p <0.01 and p <0.01, respectively) and iWAT (p <0.01
and p <0.01, respectively). As expected, transcription levels of brown adipocyte-associated markers
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like UCP1, which is highly expressed in brown fat, were extremely high compared to gWAT and iWAT.
However, although PAT UCP1 expression was lower compared to iBAT, this was to a much lower
extent, suggesting that PAT from chow-fed mice may possess thermogenic properties that have not
been recognized before.
3.2. Adipose Tissue Gene Expression Di↵erences in Chow-Fed Mice and HF-Fed Mice
In order to compare the adipogenic response of di↵erent adipose depots in obesity, mice were
fed a high-fat (HF) diet for 26 weeks and compared to chow (C)-fed counterparts. Metabolic and
phenotypic data supporting obesity and other metabolic dysfunctions in HF-fed animals are presented
in Supplementary Figure S1. The adipogenic gene expression levels were also assessed in these
30-week-old male HF-fed animals (Supplementary Figure S2A–C) and compared to their respective
chow-fed counterparts.
There were no statistically significant changes in HF-fed mice compared to chow-fed mice in
gWAT, iWAT, iBAT or PAT in FABP4 expression (Supplementary Figure S2A). However, HF-fed mice
exhibited significantly lower expression levels of PPAR  in gWAT (p < 0.01) and in PAT (p < 0.05),
and a trend towards significance in iBAT (p = 0.054), compared to their chow fed-counterparts
(Supplementary Figure S2B). We observed significantly higher expression of C/EBP↵ in iBAT (p < 0.05)
and a trend towards lower expression in gWAT (p = 0.0616) and PAT (p = 0.0515), but no significant
di↵erences in iWAT. PAT HF-fed mice have the lowest gene expression profile in FABP4 (0.71), PPAR 
(0.55) and C/EBP↵ (0.65) compared to gWAT (0.97, 0.62 and 0.68, respectively), iWAT (1.10, 0.70
and 1.13, respectively) and iBAT (1.03, 1.30 and 1.75, respectively) between all adipogenic markers,
suggesting a lower adipogenic potential in PAT HF-fed mice versus PAT chow-fed mice, compared to
the other depots.
As shown in Figure 2, we assessed the profiles of a range of genes in chow, but how will the
transcripts of key adipokines di↵er in the adipose depots induced by a HF-diet? We specifically
analysed leptin (Figure 3A) and AdipoQ expression (Figure 3B) in the gWAT, iWAT, iBAT and PAT in
30-week-old chow (C) and high-fat (HF)-fed mice. There were significantly higher gene expression
levels of leptin in HF-fed mice compared to C-fed counterparts in iWAT (p < 0.05), iBAT (p < 0.05) and
PAT (p < 0.05). Leptin in PAT HF-fed mice have a higher transcript level (3.85), followed by iWAT (3.43),
iBAT (3.40) and gWAT (1.88) when compared to their respective chow groups. AdipoQ expression was
significantly lower in gWAT HF-fed mice (p < 0.01) compared to gWAT chow-fed mice, but no other
significant changes were observed within the other depots. In general, PAT shows a similar expression
pattern in both leptin and AdipoQ expression to that of gWAT and iWAT, with HF-fed animals having
higher expression in leptin and lower expression in AdipoQ compared to their chow-fed counterparts.
As obesity, induced by a state of high caloric intake, is associated with chronic inflammation,
we next examinedwhether the pro-inflammatory cytokines IL6 (Figure 4A) and TNF↵ levels (Figure 4B)
were altered in by HF diet in gWAT, iWAT, iBAT and PAT compared to their chow-fed counterparts.
We observed >2-fold increase in IL6 levels in PAT of HF-fed mice compared to that of chow-fed mice
(p < 0.05), with no other significant changes occurring between the other depots. Expression levels of
TNF↵were significantly higher in gWAT (p <0.0001), iBAT (p <0.0001) and PAT (p < 0.05) of HF-fed
mice compared to chow-fed mice, but not in iWAT. In PAT, there was a significantly higher expression
of both IL6 and TNF↵ in HF-fed mice compared to chow-fed mice. Indeed, PAT was the only depot
wherein both pro-inflammatory markers were upregulated by HF-diet.
Next, the thermogenic properties in gWAT, iWAT, iBAT and PAT between chow- and HF-fed
mice were evaluated. UCP1 (Figure 5A) levels were significantly higher in gWAT (p < 0.01) and
iBAT (p < 0.001) in HF-fed mice, normalised to chow-gWAT and chow-iBAT, respectively, with no
significant changes displayed in iWAT or PAT. A similar transcript profile was seen in DIO2 (Figure 5B)
as UCP1, in gWAT (p < 0.001), iWAT, iBAT (p < 0.05) and PAT. ADR 3 (Figure 5C) gene expression
was significantly lower in HF-fed mice in gWAT (p < 0.01) and iWAT (p < 0.01), but higher in iBAT
(p < 0.001), with no di↵erences exhibited in PAT. Generally, PAT expression in thermogenic markers
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mirrors that of iWAT, with a tendency to lower gene expression levels in HF-fed mice compared to its
chow-fed counterpart. The expression signatures of mitochondrial function markers (Supplementary
Figure S3A–C) in gWAT, iWAT, iBAT and PAT showed no statistically significant di↵erences between
chow- and HF-fed mice.Nutrients 2020, 12, × FOR PEER REVIEW 8 of 18 
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s.e.m. Data wer analysed by n unpaired t-test between C nd HF of each depot. N = 6–12. * p < 0.05
and ** p < 0.01.
3.3. Adipose Tissue Gene Expression Di↵erences in HF-Fed Mice
Similarly to Figure 2, we then determined the depot-specific transcriptional profile of inflammatory
(Figure 6A,B), adipokine (Figure 6C) and thermogenic (Figure 6D) transcriptional profiles in HF-fed
of 30-week-old male mice, using gWAT HF-fed mice as the control for comparison. We observed
significantly higher expression of the pro-inflammatory cytokines IL6 and TNF↵ in PAT compared
to iBAT (p < 0.001 and p < 0.001, respectively) and iWAT (p < 0.0001 and p < 0.01, respectively).
In addition, there was significantly lower expression of IL6 and TNF↵ in iWAT (p < 0.01 and p < 0.05,
respectively) and iBAT (p < 0.05 and p < 0.01 respectively) compared to gWAT. Leptin levels were
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significantly lower in PAT and iBAT compared to gWAT (p < 0.01 and p < 0.0001, respectively) and
iWAT (p < 0.001 and p < 0.0001, respectively). UCP1 levels were highest in iBAT (4251.00), intermediate
in PAT (268.90) and lowest in iWAT (2.58) and gWAT (1.18). Statistically significant di↵erences were
observed in iBAT compared to gWAT (p <0.0001), iWAT (p < 0.0001) and PAT (p < 0.0001).Nutrients 2020, 12, × FOR PEER REVIEW 9 of 18 
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Figure 4. IL6 (A) and TNF↵ (B) fold change in mRNA expression in gWAT, iWAT, iBAT and PAT of
chow (C)- or high-fat (HF)-fed 30-week-old male mice. All data are relative to the housekeeping gene
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Data were analysed by an unpaired t-test between C and HF of each depot. N = 6–12. * p < 0.05 and
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3.4. Adipose Tissue Histological Di↵erences in Chow-Fed and HF-Fed Mice
To determine the di↵erences in adipocyte volume at baseline of gWAT, iWAT and PAT (Figure 7A),
we conducted histological analysis of these depots at 30 weeks old in chow-fed mice. We observed no
di↵erences in adipocyte volume between gWAT, iWAT or PAT. However, PAT had ~60% reduction in
cell volume compared to the other depots, and a trend towards a smaller depot volume compared to
gWAT (p = 0.078), with morphologically smaller cells compared to gWAT and iWAT (Figure 7C).
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Next, we assessed the response of a HF-diet on adipocyte volume compared to a standard chow
diet, histologically, in gWAT, iWAT, and PAT (Figure 7B,C). HF-fed mice had a significantly larger
adipocyte volume in gWAT (p < 0.05), iWAT (p < 0.05) and PAT (p < 0.001) compared to their chow-fed
counterparts. PAT displayed the largest volume in HF-fed mice (487.60%), followed by iWAT (376.80%)
and gWAT (338.40%) compared to their respective chow controls (100%) (Figure 7B). In addition, the
increase in adipocyte volume was also observed morphologically, in which HF-fed mice in all the
adipose tissue depots had visibly larger cells compared to their respective chow controls (Figure 7C).
To investigate whether PAT had altered adipocyte cell size distribution with regard to classical
adipose depots, we assessed the % of cells in each size category ranging from smallest to largest
size in gWAT, iWAT and PAT, from 30-week-old chow (C)- and high-fat (HF)-fed mice (Figure 7D).
While there were no significant di↵erences in the % of cells in the smallest size category across the
depots, we did observe that there was a higher percentage of smaller cells in the second smallest
size category, indicating that PAT has higher prevalence of smaller cells compared to iWAT (5 ⇥ 105
to 1 ⇥ 106 cell volume (a.u.) bin). Within the 5 ⇥ 106 to 1 ⇥ 107 cell volume (a.u.) bin, C-PAT had
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significantly fewer large adipocytes compared to C-iWAT (p < 0.05). Furthermore, within the bin
containing the largest cell size (>1 ⇥ 107 cell volume (a.u.) bin), C-PAT had significantly fewer larger
cells compared to HF-gWAT (p < 0.001) and HF-iWAT (p < 0.01) and C-iWAT had significantly less
larger cells compared to HF-gWAT (p < 0.05).Nutri nts 2020, 12, × FOR PEER REVIEW 11 of 18 
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3.5. The Relationship between Biochemical and Metabolic Parameters, Gene Expression Levels and Cell Volume
in Adipose Tissue in Chow- and HF-Fed Mice
From the collected experimental data, we investigated whether there was a relationship between
the percentage change in adipocyte volume compared to percentage body fat in both chow- and HF-fed
mice (Supplementary Figure S4). In gWAT (Supplementary Figure S4A) and PAT (Supplementary
Figure S4C), there was a strong positive linear correlation between cell volume and percentage body
fat (p < 0.05 and p < 0.001, respectively), whereas in iWAT (Supplementary Figure S4B), there was
no correlation.
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As metabolic disorders such as cardiovascular disease and obesity are associated with high
levels of inflammatory molecules and elevated levels of cholesterol, we sought to determine the
relationship between the gene expression levels of the cytokines IL6 and TNF↵ in di↵erent adipose
depots and the serum total cholesterol levels of chow (C)- and high-fat (HF)-fed mice compared to the
percentage change in adipocyte volume in gWAT (Supplementary Figure S5A–C), iWAT (Supplementary
Figure S5D–F) and PAT (Supplementary Figure S5G–I). In gWAT and PAT, there was a strong positive
linear correlation between IL6 (p < 0.01 and p < 0.01, respectively), TNF↵ (p < 0.01 and p < 0.05,
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respectively) and serum total cholesterol levels (p < 0.01, and p < 0.01, respectively), compared to the
percentage change in cell volume. In iWAT, there were no changes between IL6, TNF↵, serum total
cholesterol and cell volume.
As the level of inflammation increases, the state of obesity and therefore percentage body fat also
progresses; thus, we evaluated the relationship between the gene expression levels of IL6 and TNF↵
against the percentage body fat of chow (C)- and high-fat (HF)-fed mice in gWAT (Supplementary
Figure S6A,B), iWAT (Supplementary Figure S6C,D), iBAT (Supplementary Figure S6E–F) and PAT
(Supplementary Figure S5G–H). In gWATandPAT, therewas a strongpositive linear correlation between
IL6 (p < 0.05 and p < 0.01, respectively) and TNF↵ expression (p <0.0001, and p < 0.05, respectively)
compared to percentage body fat. In contrast to this, there was a strong negative linear correlation in
IL6 expression (p < 0.001), but no correlation in TNF↵ expression compared to percentage body fat
in iWAT. iBAT displayed a strong positive linear correlation in TNF↵ expression (p < 0.001), but no
correlation between IL6 and percentage body fat. In all cases seen in Supplementary Figures S4–S6,
the relationship between the independent variables in PAT resembles a similar correlation pattern as
demonstrated in gWAT.
4. Discussion
Our data show that in 30-week-old male mice fed a chow diet, PAT UCP1 mRNA expression is
>9000-fold higher than that of gWAT. While as expected, iBAT had the highest UCP1 expression (33462)
of all the depots examined, PAT exhibited the second highest levels (13916). UCP1 is a hallmark of
brown adipocytes and is responsible for the thermogenic properties of BAT [25]. BAT thermogenesis is
energeticallywasteful as UCP1 uncouples ATP synthesis frommitochondrial oxidative phosphorylation
to liberate heat [26]. Since the ‘rediscovery’ of functionally active BAT in humans around 10 years ago,
much attention has been given to the potential therapeutic relevance of BAT to combat obesity [27–29].
Certainly, BAT dysfunction has been linked to obesity and cardiovascular disease [27,28]. Recent
evidence, however, suggests that adult human BAT might not reside in dedicated depots but instead
resembles pockets of thermogenic brown adipocytes within white adipose tissue which may be
recruited or expanded by adrenergic stimulation or exposure to cold [30]. Such white adipose depots
that have the inherent capacity for thermogenic recruitment are referred to as beige adipose tissues
and tend to have higher mRNA expression levels of UCP1 [31]. Rodent studies have shown that
iWAT, which is the largest subcutaneous adipose tissue, represents a beige adipose depot wherein cold
exposure leads to greatly induced UCP1 expression [32].
Our results show that PAT (13916) has considerably higher UCP1 expression levels than that of
iWAT (578), suggesting the PAT in mice may resemble a beige depot that contains thermogenic active
adipocytes at baseline. Similarly, to UCP1 expression, PAT had significantly higher mRNA expression
levels of the thermogenic marker DIO2 compared to both gWAT and iWAT. DIO2 codes for an enzyme
that catalyses the conversion 3,5,30,50-tetraiodothyronine (T4) to bioactive 30,30,50-triiodothyronine
(T3). Increased DIO2 levels are associated with increased BAT function and enhanced cold-induced
adrenergic stimulation and thermogenesis. Mice with targeted disruption of the DIO2 gene have a
failure in BAT lipid formation and mitochondrial respiration, even with compensatory upregulation
of UCP1 [33]. PAT DIO2 mRNA levels at baseline were comparable to that of BAT and indicate the
potential for high thermogenic capacity of PAT. Interestingly, the transcript levels of mitochondrial
respiratory chain genes COX7A1 and COX8B was highest in iBAT and intermediate in PAT with the
latter exhibiting significantly higher expression levels compared to gWAT and iWAT. A similar pattern
of expression was observed for PGC1↵, although did not reach statistical significance in PAT compared
to gWAT and iWAT. Nevertheless, these data strongly suggest that under basal conditions PAT may
represent a beige depot with a high thermogenic capacity. Indeed, further functional experiments are
needed to explore this concept in detail.
While iBAT thermogenesis can be induced by cold or pharmacological beta-adrenergic stimulation,
it can also be activated by high-fat diet. This phenomenon, known as diet-induced thermogenesis
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has been observed in numerous rodent studies and is driven by an upregulation and/or activation of
UCP1 [34–37]. Our results showed that UCP1, DIO2 and ADR 3 mRNA levels were induced by a
26-week high-fat diet in iBAT. Interestingly, gWAT UCP1 and DIO2 mRNA levels were also induced by
a high-fat diet, although there was a significant downregulation in ADR 3 mRNA levels in gWAT.
The functional relevance of this surprising induction in gWAT UCP1 mRNA levels is unknown, and it
may be that downregulation of ADR 3 which is upstream of UCP1 in the thermogenic process in
adipocytes counteracts the UCP1 induction. Indeed, increased thyroid hormone signalling through
elevatedDIO2 gene expression has been observed in obese subjects andmay resemble thermoregulatory
disturbances [38]. Moreover, in spite of the increased gWAT UCP1 expression levels under high-fat diet
conditions, iBAT UCP1 levels remained considerably higher than that of gWAT. PAT transcript levels
for these thermogenic markers showed reductions in the high-fat group compared to the chow-fed
group, although this did not reach statistical significance. Human epicardial adipose tissue, which is
anatomically distinct from pericardial adipose tissue, also appears to have high thermogenic genetic
signatures, though its function in relation to cardiovascular physiology remains to be established [21].
Adipokines have been shown to have a major impact on metabolic function through a series
of autocrine, paracrine and endocrine actions [39,40]. One of the key adipokines associated with
metabolic health is leptin, which is produced by adipocytes and functions in body weight homeostasis.
Our results show that, of all the depots examined in this study, iBAT and PAT showed the lowest
levels of leptin mRNA expression under chow conditions. While it has been established that brown
adipocytes produce and secrete less leptin than white adipocytes, the finding that BAT and PAT have
comparable levels of leptin is further indication that PATmay resemble a beige depot as baseline [41,42].
Leptin mRNA levels are generally correlated with leptin secretion; both are related to adipocyte size
and lipid droplet morphology and are under reciprocal regulatory control with that of UCP1 mRNA
levels [43,44]. While higher leptin expression is associated with unilocularity and increased adipocyte
size, lower leptin expression is associated with reduced adipocyte size and multilocularity which are
hallmarks of brown adipocyte morphology [44]. Indeed, our histological analysis showed a very strong
trend towards reduced adipocyte size in PAT compared to both gWAT and iWAT in chow fed mice.
Undoubtedly, more direct analysis of beige characteristics in PAT, including UCP1 immunostaining are
required to confirm this characterisation. Moreover, given that cold-induced upregulation of UCP1
mRNA expression in BAT and iWAT has been observed, it would be of interest to assess if similar
interventions can induce PAT UCP1 expression [33].
In a state of high-fat-induced obesity, adipocytes increase their lipid storage capacity, resulting
in hypertrophic growth. We see evidence of this hypertrophic adipocyte growth in all the depots
examined though the increase from chow to high-fat feeding was most pronounced in PAT which
exhibited a greater than four-fold increase in adipocyte size. Obesogenic hypertrophic adipocyte growth
is associated with pro-inflammatory responses that promote insulin resistance and cardiovascular
disease [40,45]. We observed that, of all the depots examined, only the PAT showed a significant increase
in the mRNA expression of the two key pro-inflammatory cytokines in mouse adipose tissue, namely
IL6 and TNF↵. These results suggest that the high-fat diet may be potentiating pro-inflammatory
macrophage infiltration and subsequent metabolic dysfunction. Indeed, human cardiac adipose depots
such as pericardial and epicardial adipose tissue have been shown to have a high pro-inflammatory
status that may be involved in the pathogenesis of coronary artery disease [39,46]. The visceral adipose
depots in both rodent and human studies have been well documented to be more pro-inflammatory
than subcutaneous depots and explain why visceral adipose depots are more closely associated with
metabolic disease [45,47]. This depot-specific inflammatory response maybe due, at least in part, to the
observation that visceral adipose tissue expands by hypertrophy whereas subcutaneous depots tend to
expand by hyperplastic growth, which is a more healthy form of obesogenic expansion [45]. To this
end, metabolically healthy obesity is associated with subcutaneous adipose expansion versus that of
visceral [47,48]. To this end, our correlation analysis revealed a strong positive association between
pro-inflammatory cytokine mRNA expression and adipocyte size in PAT and gWAT but not iWAT.
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We also observed a strong positive correlation between pro-inflammatory cytokine mRNA expression
and both body fat % and serum cholesterol in PAT and gWAT but not iWAT. In fact, iWAT showed the
opposite trend. Given that dense epicardial adipose tissue macrophage infiltrate in humans has been
shown to be involved in the pathogenesis of necrotic plaque accretion in the vasculature, our results
potentially point to a similar role for mouse pericardial adipose tissue.
Taken together, our results point to both a thermogenic and pro-inflammatory profile of mouse
pericardial adipose tissue which represents a unique and previously unreported finding which is
of potential and experimental clinical importance. Our results suggest that mouse PAT may have
functional qualities that resemble both BAT as well as visceral adipose tissue. While further functional
studies are required to confirm the physiological relevance of the genomic and histological analyses
observed here, our results provide compelling evidence that mouse pericardial adipose tissue deserves
closer attention in metabolic research.
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